IMCR — Immunocore Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Immunocore Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	20-F	20-F	10-K	10-K
Standards:	IFRS	IFRS	IFRS	USG	USG
Status:	fx Final	fx Final	fx Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	98.1	177	322	402	443
Net Total Accounts Receivable
Net Total Receivables	60.4	22.8	23.2	57.1	61.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	165	209	355	474	529
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	72.8	50.4	42.7	38.8	42.7
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	246	270	408	527	597
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	112	75.2	82.8	101	139
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	227	194	176	188	228
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	19.6	75.7	232	339	369
Total Liabilities & Shareholders' Equity	246	270	408	527	597
Total Common Shares Outstanding